腎交感神經阻斷術導管的開發平台 - 開發階段，市場區隔，地區，法規途徑，主要企業

本報告提供腎交感神經阻斷術導管的開發中產品調查分析，包含各種正在開發階段的產品的比較分析，及進行中的臨床試驗資料等全面性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

• 腎交感神經阻斷術導管 - 開發中產品:各開發階段
• 腎交感神經阻斷術導管 - 開發中產品:各市場區隔
• 腎交感神經阻斷術導管 - 開發中產品:各地區
• 腎交感神經阻斷術導管 - 開發中產品:各法規途徑
• 腎交感神經阻斷術導管 - 開發中產品:各估計核准日
• 腎交感神經阻斷術導管 - 進行中的臨床試驗

第4章 腎交感神經阻斷術導管 - 正在開發的開發中產品:各企業

• 腎交感神經阻斷術導管企業 - 開發中產品:各開發階段
• 腎交感神經阻斷術導管 - 開發中產品:各開發階段

第5章 腎交感神經阻斷術導管的企業和產品概要

• Abbott Vascular Inc:企業概要
  • Abbott Vascular Inc:開發中產品和進行中的臨床試驗概要
• Ablative Solutions Inc:企業概要
  • Ablative Solutions Inc:開發中產品和進行中的臨床試驗概要
• Brattea:企業概要
  • Brattea:開發中產品和進行中的臨床試驗概要
• CryoMedix, LLC.:企業概要
  • CryoMedix, LLC.:開發中產品和進行中的臨床試驗概要
• Handok-Kalos Medical:企業概要
  • Handok-Kalos Medical:開發中產品和進行中的臨床試驗概要
• Johns Hopkins University:企業概要
  • Johns Hopkins University:開發中產品和進行中的臨床試驗概要
• Kona Medical Inc:企業概要
  • Kona Medical Inc:開發中產品和進行中的臨床試驗概要
• Lepu Medical Technology (北京) Co Ltd:企業概要
  • Lepu Medical Technology (北京) Co Ltd:開發中產品和進行中的臨床試驗概要
• Lifetech Scientific (深圳) Co Ltd:企業概要
  • Lifetech Scientific (深圳) Co Ltd:開發中產品和進行中的臨床試驗概要
• Mayo Clinic:企業概要
  • Mayo Clinic:開發中產品和進行中的臨床試驗概要
• Medtronic Plc:企業概要
  • Medtronic Plc:開發中產品和進行中的臨床試驗概要
• MicroPort Scientific Corp:企業概要
  • MicroPort Scientific Corp:開發中產品和進行中的臨床試驗概要
• Northwind Medical Inc:企業概要
  • Northwind Medical Inc:開發中產品和進行中的臨床試驗概要
• ReCor Medical Inc:企業概要
  • ReCor Medical Inc:開發中產品和進行中的臨床試驗概要
• Renal Dynamics, LLC:企業概要
  • Renal Dynamics, LLC:開發中產品和進行中的臨床試驗概要
• Renaly Ltd:企業概要
  • Renaly Ltd:開發中產品和進行中的臨床試驗概要
• Shanghai AngioCare Medical Technology Co Ltd:企業概要
  • Shanghai AngioCare Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
• Shanghai Golden Leaf Medtech Co Ltd:企業概要
  • Shanghai Golden Leaf Medtech Co Ltd:開發中產品和進行中的臨床試驗概要
• SoniVie Ltd.:企業概要
  • SoniVie Ltd.:開發中產品和進行中的臨床試驗概要
• Sound Interventions, Inc.:企業概要
  • Sound Interventions, Inc.:開發中產品和進行中的臨床試驗概要
• St. Jude Medical LLC:企業概要
  • St. Jude Medical LLC:開發中產品和進行中的臨床試驗概要
• Suzhou Rainmed Medical Technology Co Ltd:企業概要
  • Suzhou Rainmed Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
• Suzhou Xinmai Medical Equipment Co Ltd:企業概要
  • Suzhou Xinmai Medical Equipment Co Ltd:開發中產品和進行中的臨床試驗概要
• Symple Surgical Inc:企業概要
  • Symple Surgical Inc:開發中產品和進行中的臨床試驗概要
• Tel Aviv University:企業概要
  • Tel Aviv University:開發中產品和進行中的臨床試驗概要
• Terumo Interventional Systems:企業概要
  • Terumo Interventional Systems:開發中產品和進行中的臨床試驗概要
• University of Sydney:企業概要
  • University of Sydney:開發中產品和進行中的臨床試驗概要
• Venus Medtech Hangzhou Inc:企業概要
  • Venus Medtech Hangzhou Inc:開發中產品和進行中的臨床試驗概要
• Verve Medical, Inc.:企業概要
  • Verve Medical, Inc.:開發中產品和進行中的臨床試驗概要

第6章 腎交感神經阻斷術導管 - 最近的發展

第7章 附錄

Abstract

Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension. GlobalData's Medical Devices sector report, "Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Renal Denervation Catheters report provides key information and data related to:

Extensive coverage of the Renal Denervation Catheters under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Renal Denervation Catheters pipeline products.

Review of Recent Developments in the segment / industry

The Renal Denervation Catheters report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Renal Denervation Catheters under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies' revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

• Extensive coverage of the Renal Denervation Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Renal Denervation Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Renal Denervation Catheters Overview

3 Products under Development

• 3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
• 3.2 Renal Denervation Catheters - Pipeline Products by Segment
• 3.3 Renal Denervation Catheters - Pipeline Products by Territory
• 3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
• 3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
• 3.6 Renal Denervation Catheters - Ongoing Clinical Trials

4 Renal Denervation Catheters - Pipeline Products under Development by Companies

• 4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
• 4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development

5 Renal Denervation Catheters Companies and Product Overview

• 5.1 Abbott Vascular Inc Company Overview
  • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Ablative Solutions Inc Company Overview
  • 5.2.1 Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Brattea Company Overview
  • 5.3.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 CryoMedix, LLC. Company Overview
  • 5.4.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Handok-Kalos Medical Company Overview
  • 5.5.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Johns Hopkins University Company Overview
  • 5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Kona Medical Inc Company Overview
  • 5.7.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Lepu Medical Technology (Beijing) Co Ltd Company Overview
  • 5.8.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.9.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Mayo Clinic Company Overview
  • 5.10.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Medtronic Plc Company Overview
  • 5.11.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 MicroPort Scientific Corp Company Overview
  • 5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Northwind Medical Inc Company Overview
  • 5.13.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 ReCor Medical Inc Company Overview
  • 5.14.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Renal Dynamics, LLC Company Overview
  • 5.15.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Renaly Ltd Company Overview
  • 5.16.1 Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Shanghai AngioCare Medical Technology Co Ltd Company Overview
  • 5.17.1 Shanghai AngioCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Shanghai Golden Leaf Medtech Co Ltd Company Overview
  • 5.18.1 Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 SoniVie Ltd. Company Overview
  • 5.19.1 SoniVie Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Sound Interventions, Inc. Company Overview
  • 5.20.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 St. Jude Medical LLC Company Overview
  • 5.21.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Suzhou Rainmed Medical Technology Co Ltd Company Overview
  • 5.22.1 Suzhou Rainmed Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Suzhou Xinmai Medical Equipment Co Ltd Company Overview
  • 5.23.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Symple Surgical Inc Company Overview
  • 5.24.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Tel Aviv University Company Overview
  • 5.25.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Terumo Interventional Systems Company Overview
  • 5.26.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 University of Sydney Company Overview
  • 5.27.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 Venus Medtech Hangzhou Inc Company Overview
  • 5.28.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Verve Medical, Inc. Company Overview
  • 5.29.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Renal Denervation Catheters- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Renal Denervation Catheters - Pipeline Products by Stage of Development
• Renal Denervation Catheters - Pipeline Products by Segment
• Renal Denervation Catheters - Pipeline Products by Territory
• Renal Denervation Catheters - Pipeline Products by Regulatory Path
• Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
• Renal Denervation Catheters - Ongoing Clinical Trials
• Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
• Renal Denervation Catheters - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Renal Denervation Catheters - Pipeline Products by Stage of Development
• Renal Denervation Catheters - Pipeline Products by Segment
• Renal Denervation Catheters - Pipeline Products by Territory
• Renal Denervation Catheters - Pipeline Products